<DOC>
	<DOCNO>NCT02115113</DOCNO>
	<brief_summary>The purpose study , start Italian clinical practice liver transplantation , optimize immunosuppressive therapy , consider specific patient characteristic alcoholic cirrhosis , hepatitis C virus ( HCV ) , hepatocellular carcinoma ( HCC ) , short/long-term implication . Then efficacy safety calcineurin inhibitor ( CNI ) -withdrawal regimen evaluate comparison CNI-minimization regimen .</brief_summary>
	<brief_title>REnal Function Liver Transplantation : Everolimus With Calcineurin Inhibitor ( CNI ) -Sparing sTrategy</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Inclusion criterion Baseline : Male female liver transplant recipient ≥ 18 year age , treat tacrolimusbased immunosuppressive regimen , receive induction therapy i.v . steroid per local clinical practice . Recipients fullsize technically modify liver allograft eligible 4 week ( ± 7 day ) liver transplantation . Allograft function acceptable level time Baseline define AST , ALT , total bilirubin level ≤ 3 time ULN INR &lt; 1.5 time ULN . Abbreviated MDRD4 eGFR ≥ 30 mL/min/1.73m2 . Serum creatinine result obtain within 5 day prior Baseline acceptable . Inclusion criterion Randomization : Effective tacrolimus minimization , confirm stable blood trough level two month prior randomization , i.e . verification last two tacrolimus blood trough level ≤ 5 ng/mL two month prior randomization . Investigators make adjustment tacrolimus dose continue target trough level ≤ 5 ng/mL prior randomization . Abbreviated MDRD4 eGFR ≥ 30 mL/min/1.73m2 . Serum creatinine result obtain within 5 day prior Visit 5 acceptable . Exclusion criterion Baseline : Patients recipient multiple solid organ transplant , ( e.g. , multivisceral combine liverkidney transplant ) , previously receive organ tissue transplant , receive AB0 incompatible transplant . Patients experience one episode treat biopsy proven acute rejection ( BANFF ≥ 3 RAI ≥ 7 ) one steroidresistant acute rejection . Patients require renal replacement therapy . Patients confirm spot urine protein/creatinine ratio indicate ≥1.0 g/24 hr proteinuria . History malignancy organ system within past 5 year whether evidence local recurrence metastasis , nonmetastatic basal squamous cell carcinoma skin HCC . Exclusion criterion Randomization : Patients experience two episode treat biopsy proven acute rejection ( BANFF ≥ 3 RAI ≥ 7 ) since transplantation one steroidresistant acute rejection runin period . Patients confirm spot urine protein/creatinine ratio indicate ≥ 3.0 g/24 hr proteinuria .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Liver transplantation , everolimus , CNI-minimization , CNI-elimination , renal function</keyword>
</DOC>